牛叉诊股

[{"date":"2026.08.06","stock":"-1.00","trade":"0.32","ind":"0.57"},{"date":"2026.08.05","stock":"-2.68","trade":"-0.59","ind":"1.47"},{"date":"2026.08.04","stock":"-1.30","trade":"0.61","ind":"0.33"},{"date":"2026.08.03","stock":"-0.80","trade":"0.76","ind":"-0.59"},{"date":"2026.07.31","stock":"0.15","trade":"1.71","ind":"0.72"},{"date":"2026.07.30","stock":"1.55","trade":"-0.93","ind":"-0.62"},{"date":"2026.07.29","stock":"1.53","trade":"0.54","ind":"0.40"},{"date":"2026.07.28","stock":"0.24","trade":"-0.02","ind":"-1.16"},{"date":"2026.07.27","stock":"1.48","trade":"3.54","ind":"1.15"},{"date":"2026.07.24","stock":"-2.94","trade":"-3.55","ind":"-1.61"},{"date":"2026.07.23","stock":"-0.65","trade":"0.55","ind":"0.25"},{"date":"2026.07.22","stock":"0.35","trade":"0.01","ind":"0.07"},{"date":"2026.07.21","stock":"-1.75","trade":"-1.38","ind":"1.79"},{"date":"2026.07.20","stock":"1.23","trade":"0.06","ind":"0.85"},{"date":"2026.07.17","stock":"-3.30","trade":"-4.74","ind":"-3.05"},{"date":"2026.07.16","stock":"6.65","trade":"1.47","ind":"-1.85"},{"date":"2026.07.15","stock":"2.02","trade":"2.87","ind":"-0.29"},{"date":"2026.07.14","stock":"0.90","trade":"1.54","ind":"1.36"},{"date":"2026.07.13","stock":"3.59","trade":"2.88","ind":"-2.06"},{"date":"2026.07.10","stock":"2.42","trade":"1.37","ind":"-1.00"},{"date":"2026.07.09","stock":"-1.20","trade":"-0.25","ind":"1.65"}]

同仁堂,上证指数,中药指数

压力支撑

该股压力位为24.70元，支撑位为24.29元。

[{"text":"\u538b\u529b\u4f4d","value":"24.70","date":1785945600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"24.29","date":1785945600,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.4资金面打败了14%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：08月07日 08:07

机构今日流向(万元)	-1517.44	机构5日流向(万元)	-3129.33
机构10日流向(万元)	-5002.20	机构20日流向(万元)	-1863.04

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少85102.18万股，其中基金净增仓4家，主力净减仓265家，暂未发现中长期投资价值。

截止2026-06-30，共5家主力机构（基金5家），持仓量总计785.71万股，占流通A股0.57%
其中，基金持仓与2025-12-31相比：
增仓：4家，增持 97.02万股
减仓：0家，减持 0万股
新出现在主力名单中：1家，持有3.98万股
从主力名单中消失：266家，原持有85203.18万股

消息面诊股

诊断结果：5.5消息面打败了47%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-05-27
一般消息	募资投向	公司购买资产	2026-05-27
一般消息	高管变动	工作调整	2026-04-07
利好	分红转增	10派5元(含税)	2026-03-31
一般消息	重大事项	关联交易	2026-01-17
一般消息	重大事项	关联交易	2025-11-29
一般消息	重大事项	关联交易	2025-09-30
一般消息	分红转增	不分配不转增	2025-08-30
一般消息	高管变动	委员会调整	2025-08-11

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：7.7行业面打败了74%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.08.06","price":"0.57","value":"0.32"},{"date":"2026.08.05","price":"1.47","value":"-0.59"},{"date":"2026.08.04","price":"0.33","value":"0.61"},{"date":"2026.08.03","price":"-0.59","value":"0.76"},{"date":"2026.07.31","price":"0.72","value":"1.71"},{"date":"2026.07.30","price":"-0.62","value":"-0.93"},{"date":"2026.07.29","price":"0.40","value":"0.54"},{"date":"2026.07.28","price":"-1.16","value":"-0.02"},{"date":"2026.07.27","price":"1.15","value":"3.54"},{"date":"2026.07.24","price":"-1.61","value":"-3.55"},{"date":"2026.07.23","price":"0.25","value":"0.55"},{"date":"2026.07.22","price":"0.07","value":"0.01"},{"date":"2026.07.21","price":"1.79","value":"-1.38"},{"date":"2026.07.20","price":"0.85","value":"0.06"},{"date":"2026.07.17","price":"-3.05","value":"-4.74"},{"date":"2026.07.16","price":"-1.85","value":"1.47"},{"date":"2026.07.15","price":"-0.29","value":"2.87"},{"date":"2026.07.14","price":"1.36","value":"1.54"},{"date":"2026.07.13","price":"-2.06","value":"2.88"},{"date":"2026.07.10","price":"-1.00","value":"1.37"},{"date":"2026.07.09","price":"1.65","value":"-0.25"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	陇神戎发	101.62%	11.44%	5.4分
2	珍宝岛	39.39%	6.10%	3.8分
3	上海凯宝	27.56%	3.51%	5.3分
4	片仔癀	24.88%	-0.32%	5.4分
5	-	22.08%	13.88%	分
6	中恒集团	15.79%	0.46%	4.9分
7	新光药业	15.61%	7.49%	5.9分
8	-	15.46%	6.02%	分
9	东阿阿胶	15.06%	-2.52%	5.8分
10	天目药业	13.43%	10.62%	6.3分
11	济川药业	12.41%	0.59%	5.4分
12	益佰制药	12.06%	0.57%	4.7分
13	九芝堂	12.00%	2.26%	5.4分
14	汉森制药	11.82%	6.71%	5.4分
15	天士力	10.33%	-2.46%	4.9分
16	健民集团	10.26%	6.23%	6.3分
17	昆药集团	10.06%	-3.74%	4.7分
18	亚宝药业	9.36%	3.90%	5.9分
19	佛慈制药	8.95%	1.70%	5.9分
20	红日药业	8.77%	0.00%	4.9分
21	古汉医药	8.55%	7.61%	5.4分
22	信邦制药	8.12%	-1.35%	5.2分
23	益盛药业	8.01%	-0.77%	5.5分
24	同仁堂	7.40%	-5.52%	4.8分
25	康美药业	7.20%	-0.74%	3.6分
26	以岭药业	7.04%	-2.22%	5.2分
27	葵花药业	7.04%	-4.32%	4.9分
28	华神科技	7.00%	2.41%	5.9分
29	寿仙谷	6.96%	0.00%	5.0分
30	新天药业	6.04%	5.47%	5.8分
31	振东制药	5.70%	3.09%	5.5分
32	华润三九	5.54%	-3.67%	5.5分
33	华润江中	5.49%	-4.80%	5.4分
34	仁和药业	5.13%	-2.91%	4.9分
35	佐力药业	5.03%	-2.71%	5.5分
36	恩威医药	4.97%	7.96%	6.0分
37	云南白药	4.82%	-3.91%	5.7分
38	康恩贝	4.18%	-1.85%	5.4分
39	ST金花	4.04%	2.73%	5.8分
40	ST葫芦娃	3.62%	5.07%	5.4分
41	太龙药业	3.25%	14.22%	6.2分
42	广誉远	2.76%	-4.27%	5.0分
43	千金药业	2.75%	0.31%	5.9分
44	特一药业	2.72%	9.40%	6.0分
45	方盛制药	2.51%	-0.53%	5.2分
46	精华制药	2.46%	-0.75%	5.1分
47	奇正藏药	2.20%	-2.30%	5.3分
48	众生药业	2.05%	9.64%	6.5分
49	ST百灵	2.03%	-0.66%	5.6分
50	羚锐制药	1.84%	-5.49%	5.3分
51	维康药业	1.82%	30.27%	6.5分
52	ST嘉应	1.51%	4.33%	5.7分
53	吉林敖东	1.40%	-1.20%	4.9分
54	马应龙	1.39%	-3.50%	5.7分
55	康缘药业	0.99%	-3.23%	4.7分
56	白云山	0.80%	-3.65%	5.0分
57	步长制药	0.00%	-0.06%	4.8分
58	桂林三金	-0.08%	-0.83%	6.0分
59	太极集团	-0.91%	-0.46%	4.3分
60	达仁堂	-2.61%	-3.73%	5.1分
61	沃华医药	-3.18%	2.18%	6.1分
62	盘龙药业	-7.48%	5.14%	4.9分
63	华森制药	-9.47%	4.33%	6.3分
64	三力制药	-9.47%	11.79%	5.5分
65	康惠股份	-9.96%	20.55%	5.4分
66	粤万年青	-13.63%	17.81%	6.1分
67	ST万邦	-16.80%	9.09%	7.3分
68	*ST香雪	-17.64%	19.28%	5.7分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.7基本面打败了46%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（70分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/107 ， 53/107。

[{"date":"2026-03-31","value":"3.40","vol":"2.21"},{"date":"2025-12-31","value":"8.86","vol":"-2.33"},{"date":"2025-09-30","value":"8.77","vol":"4.80"},{"date":"2025-06-30","value":"7.10","vol":"4.03"},{"date":"2025-03-31","value":"4.32","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	3.40	8.86	8.77	7.10	4.32
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"41.66","vol":"55.05"},{"date":"2025-12-31","value":"42.87","vol":"52.85"},{"date":"2025-09-30","value":"43.86","vol":"53.29"},{"date":"2025-06-30","value":"44.29","vol":"53.82"},{"date":"2025-03-31","value":"45.51","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	41.66	42.87	43.86	44.29	45.51
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 45/107 ， 50/107。

[{"date":"2026-03-31","value":"-11.59","vol":"-5.58"},{"date":"2025-12-31","value":"-7.21","vol":"-6.76"},{"date":"2025-09-30","value":"-3.70","vol":"-7.84"},{"date":"2025-06-30","value":"0.06","vol":"-7.78"},{"date":"2025-03-31","value":"0.16","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-11.59	-7.21	-3.70	0.06	0.16
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-19.07","vol":"1.06"},{"date":"2025-12-31","value":"-22.07","vol":"-80.25"},{"date":"2025-09-30","value":"-12.78","vol":"-2.78"},{"date":"2025-06-30","value":"-7.39","vol":"2.25"},{"date":"2025-03-31","value":"1.10","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-19.07	-22.07	-12.78	-7.39	1.10
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/107 ， 56/107。

[{"date":"2026-03-31","value":"0.15","vol":"0.12"},{"date":"2025-12-31","value":"0.56","vol":"0.47"},{"date":"2025-09-30","value":"0.42","vol":"0.35"},{"date":"2025-06-30","value":"0.31","vol":"0.24"},{"date":"2025-03-31","value":"0.17","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.15	0.56	0.42	0.31	0.17
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.27","vol":"0.59"},{"date":"2025-12-31","value":"0.92","vol":"2.34"},{"date":"2025-09-30","value":"0.68","vol":"1.72"},{"date":"2025-06-30","value":"0.50","vol":"1.17"},{"date":"2025-03-31","value":"0.27","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.27	0.92	0.68	0.50	0.27
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"20.21","vol":"5.83"},{"date":"2025-12-31","value":"17.86","vol":"30.77"},{"date":"2025-09-30","value":"0.98","vol":"10.53"},{"date":"2025-06-30","value":"24.94","vol":"22.82"},{"date":"2025-03-31","value":"15.78","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	20.21	17.86	0.98	24.94	15.78
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.32","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.27","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.32	-	0.27	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 49/107 ， 44/107。

[{"date":"2026-03-31","value":"3.77","vol":"2.97"},{"date":"2025-12-31","value":"3.59","vol":"2.94"},{"date":"2025-09-30","value":"3.45","vol":"3.09"},{"date":"2025-06-30","value":"3.30","vol":"2.94"},{"date":"2025-03-31","value":"3.45","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	3.77	3.59	3.45	3.30	3.45
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.17","vol":"2.23"},{"date":"2025-12-31","value":"1.89","vol":"2.15"},{"date":"2025-09-30","value":"1.82","vol":"2.24"},{"date":"2025-06-30","value":"1.77","vol":"2.15"},{"date":"2025-03-31","value":"1.87","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	2.17	1.89	1.82	1.77	1.87
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 26/107 ， 21/107。

[{"date":"2026-03-31","value":"29.34","vol":"31.94"},{"date":"2025-12-31","value":"30.18","vol":"32.43"},{"date":"2025-09-30","value":"32.57","vol":"31.59"},{"date":"2025-06-30","value":"33.70","vol":"32.45"},{"date":"2025-03-31","value":"32.65","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	29.34	30.18	32.57	33.70	32.65
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.65","vol":"0.66"},{"date":"2025-12-31","value":"0.68","vol":"0.67"},{"date":"2025-09-30","value":"0.76","vol":"0.76"},{"date":"2025-06-30","value":"0.80","vol":"0.75"},{"date":"2025-03-31","value":"0.77","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.65	0.68	0.76	0.80	0.77
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。

研究机构	评级日期	最新评级	上次评级
兴业证券	2026-07-26	增持
国泰海通证券	2026-05-17	买入
华创证券	2026-05-15	增持

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"14.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"16.69","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.26","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"11.89","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"14.04","blueLineValue":"1.02","type":"YC"}]

[同仁堂]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]